ERLINA PLUS XR 25/5/1000MG TAB

ERLINA PLUS XR is a combination tablet containing empagliflozin, linagliptin, and metformin HCl. This triple-action formulation is designed to help manage type 2 diabetes by working through multiple mechanisms: improving insulin sensitivity, enhancing glucose excretion through the kidneys, and slowing carbohydrate digestion. The extended-release formulation provides sustained therapeutic effect throughout the day. Suitable for patients requiring comprehensive glycemic control. Always use as directed by your healthcare provider.